Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease provides a direct relationship between the cardiac and hepatic pathologies providing the link between the heart and liver showing how liver-diseases predispose to impairment in heart functioning and vice versa. Considering the growing number of patients living (and living longer) with heart failure and/or congenital heart disease, it is important to know when and how to test for liver disease in this population, how to interpret abnormal test results, and what management is appropriate. Coverage includes what should be done for patients to limit, avoid, or postpone the impairment in the liver functioning induced by heart diseases and the impairment in the heart functioning induced by liver diseases, on the basis of scientific-exposed evidence and patho-physiology knowledge.
This comprehensive, extended review of the medical literature is perfect for researchers interested in the connection between cardiology and hepatology as well as clinicians making therapeutic decisions for patients suffering from heart or liver chronic diseases.
- Reviews and discusses all current knowledge about the interactions between heart and liver pathologies
- Provides guidance on current topics surrounding the assessment of the liver in heart failure
- Presents important clinical cardiovascular assessments in cirrhotic patients
I. Liver and heart
1. The liver
2. Nonalcoholic fatty liver disease and cardiovascular disease
3. Pathophysiologic changes in chronic heart failure affecting drug pharmacokinetics
4. Drugs at the crossroads of heart and liver
5. Obstruction of the liver circulation
II. Hepatobiliary system in heart failure
6. Epidemiology of liver diseases in heart failure
7. Cardio-hepatology: liver function tests in heart failure
8. Prognostic value of liver assessment (including liver stiffness measurement) in cardiovascular diseases
9. Passive liver congestion and hypoxic hepatitis
10. Histopathology of the liver in heart failure
III. Cardiovascular system in liver failure
12. Sepsis and the liver
13. Bleeding and thrombosis in cirrhosis
14. Peripheral vasculature in portal hypertension
15. Cirrhotic cardiomyopathy
16. Cardiovascular dysfunction in liver diseases: pediatric perspectives
17. Hepatorenal syndrome and acute kidney injury in cirrhosis
18. Cardiopulmonary considerations for the anesthetic management of liver transplantation
19. Cardiovascular assessment before liver transplantation
20. Predicting cardiovascular complications after liver transplantation
Dr. Taniguchi is a cardiologist at the Department of Cardiovascular Medicine at Osaka University Graduate School of Medicine, Japan, with research interests in crosstalk between heart and other organs in heart failure. He has won several awards for research including the 2014 Japan Circulation Society (Kinki Regional Scientific Meeting) Young Investigators Award and the Japan Society of Ultrasound Sonics in Medicine Prize for Encouragement. He served as a representative of U-40 heart failure network in Japan in 2018. He is also a member of Japan International Young Committee at Japan Circulation Society from 2018. Dr. Lee is a professor of Medicine (Hepatology) at the University of Calgary, Canada, with research interests in cardiovascular complications of cirrhosis and viral hepatitis. He has won several awards for teaching and research including the Queen Elizabeth II Golden Jubilee Medal in 2002, the Canadian Association of the Study of Liver (CASL) Distinguished Service Award, 2015, CASL/CLF Gold Medal in 2021, and has lectured in more than 50 countries. He is a past-president of CASL, International Association for Study of Liver (IASL), and the International Ascites Club. He served as editor-in-chief of Liver International from 2008 to 2013. He chairs the steering committee for the Canadian HCV database registry CANUHC (Canadian Network Undertaking against Hepatitis C).
